FindTrial
Sign In

Kaksoissokkoutettu kliininen hoitotutkimus: Rahapeliriippuvuuden hoitaminen opiaattisalpaaja naltreksonilla ja oppimismallilla - PELI2

Kaksoissokkoutettu kliininen hoitotutkimus: Rahapeliriippuvuuden hoitaminen opiaattisalpaaja naltreksonilla ja oppimismallilla - PELI2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-021123-26-FI
Enrollment
Unknown
Registered
2010-06-15
Start date
2010-10-29
Completion date
Unknown
Last updated
2013-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathological gambling dependence MedDRA version: 12.1 Level: LLT Classification code 10017657 Term: Gambling pathological

Interventions

Product Name: Naltrexone Pharmaceutical Form: Tablet

Sponsors

National Institute for Health and Welfare
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Peliriippuvuus Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Vakava mielenterveyden häiriö, alkoholiriippuvuus, huumeiden käyttö

Design outcomes

Primary

MeasureTime frame
Main Objective: Peliriippuvuuden hoito;Secondary Objective: ;Primary end point(s): YBOCS pisteet—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026